BR100 Decreased By (-0.87%)
BR30 Decreased By (-1.57%)
KSE100 Decreased By (-0.77%)
KSE30 Decreased By (-0.77%)
AGHA 6.68 No Change ▼ 0.00 (0%)
BECO 4.36 Decreased By ▼ -0.01 (-0.23%)
BML 56.34 Decreased By ▼ -0.98 (-1.71%)
BOP 30.08 Decreased By ▼ -0.27 (-0.89%)
CNERGY 12.91 Decreased By ▼ -0.21 (-1.6%)
CSIL 5.35 Decreased By ▼ -0.06 (-1.11%)
FCCL 51.91 Decreased By ▼ -0.88 (-1.67%)
FFL 14.48 Decreased By ▼ -0.24 (-1.63%)
FNEL 1.21 Increased By ▲ 0.09 (8.04%)
KEL 6.10 Increased By ▲ 0.01 (0.16%)
KOSM 5.94 Increased By ▲ 0.21 (3.66%)
LOTCHEM 26.22 Decreased By ▼ -0.24 (-0.91%)
MLCF 91.40 Decreased By ▼ -1.76 (-1.89%)
NBP 163.48 Decreased By ▼ -1.18 (-0.72%)
NCPL 53.35 Decreased By ▼ -2.31 (-4.15%)
NPL 58.20 Decreased By ▼ -2.96 (-4.84%)
OGDC 312.80 Decreased By ▼ -3.93 (-1.24%)
PACE 9.80 Decreased By ▼ -0.07 (-0.71%)
PAEL 35.06 Decreased By ▼ -0.57 (-1.6%)
PIBTL 14.68 No Change ▼ 0.00 (0%)
PPL 221.40 Decreased By ▼ -5.51 (-2.43%)
PRL 90.97 Decreased By ▼ -2.05 (-2.2%)
PTC 59.02 Decreased By ▼ -1.24 (-2.06%)
SSGC 23.27 Decreased By ▼ -0.54 (-2.27%)
TBL 8.77 Increased By ▲ 0.02 (0.23%)
TELE 7.55 Decreased By ▼ -0.25 (-3.21%)
TPL 21.98 Decreased By ▼ -0.37 (-1.66%)
TPLP 12.55 Decreased By ▼ -0.42 (-3.24%)
TREET 21.77 Decreased By ▼ -0.39 (-1.76%)
TRG 56.40 Decreased By ▼ -0.16 (-0.28%)
By

BERLIN: Novartis on Thursday posted a slightly more optimistic full-year earnings forecast, citing the strong growth of drugs such as breast cancer drug Kisqali during the second quarter.

The Swiss drugmaker said it now expects core operating income to grow in the low teens, from the low double-digits cited previously.

Comments

Comments are closed for this article.